Design and synthesis of dual-target CDK9-EZH2 inhibitors using a pharmacophore fusion strategy
{{output}}
Cyclin-dependent kinase 9 (CDK9), a key member of the CDK family, plays a crucial role in transcriptional regulation. As its expression is dysregulated in various cancers, CDK9 is regarded as a promising therapeutic target. However, the clinical efficacy of tr... ...
